Adam Koppel, M.D., Ph.D.
DirectoratFoghorn Therapeutics· In the 2024 proxy
Adam Koppel, M.D., Ph.D. is Director of Foghorn Therapeutics.
Experience
- Foghorn TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -68%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?